April 2026

Customer Notification: IMPORTANT UPDATE re Murex HBsAg Version 3

Apr
16

Reason for Notification:

On 26th March the NVRL posted a Customer Notification regarding suspension of this assay following receipt of a Field Safety Notice from the supplier, Diasorin.

We have been informed that the date of availability of this kit is now 27th MAY 2026.

NVRL apologises for any issues to our service users; these are outside our control.

 

Please contact the NVRL Clinical team if you have any queries.

Phone 01-7164401, and select option 2.

 

Posted By Helen.Dawkins read more

CN-26-9: Customer notification: Luminex NxTAG Respiratory Screen – reverting to v1 of this assay

Apr
13

As of 13 April 2026, for stock management purposes, the NVRL will temporarily revert to version 1 of the Luminex NxTAG Respiratory Screen. 

The test code remains LRSC.

During this time, we will not be reporting human metapneumovirus (hMPV) in line with the previously issued notice (October 2024).  However, testing for hMPV may be specifically requested if clinically indicated.  

Please contact the NVRL Clinical team on (01) 7164401 to make these requests.  Testing with v2 of the assay will resume later in the year.

 

Posted By Brian O'Grady read more

CN-26-8: Customer Notification: Labelling requirements for samples from suspected or confirmed mpox cases

Apr
07

Laboratories submitting samples from suspected or confirmed mpox cases to the NVRL for testing must:

  • Indicate the requirement for mpox testing on the external packaging
  • Ensure that all samples – including both mpox diagnostic swabs and other sample types – are clearly marked as “probable (or confirmed) mpox”

For detailed sampling, packaging and transport requirements, please refer to the NVRL User Manual and current national guidelines – Laboratory Testing in Patients with confirmed or clinically suspected mpox (V 4.5, published 18/03/2026)

Posted By Helen.Dawkins read more